Medical Action Industries 1st Quarter Earnings Call To Take Place On August 1, 2012
Medical Action Industries Inc. (NASDAQ/MDCI), announced today that it
will hold a conference call to present its financial results for the
quarter ended June 30, 2012 on Wednesday, August 1, 2012 at 10:00 a.
Medical Action Industries Inc. (NASDAQ/MDCI), announced today that it will hold a conference call to present its financial results for the quarter ended June 30, 2012 on Wednesday, August 1, 2012 at 10:00 a.m. (ET). Paul D. Meringolo, Medical Action’s President and Chief Executive Officer further advised that our results of operations for the quarter ended June 30, 2012 are scheduled to be released on Wednesday, August 1, 2012 before the market opens. The conference call will be conducted by Mr. Meringolo, Mr. John Sheffield, Chief Financial Officer and Mr. Brian Baker, Corporate Controller. The conference call will be simultaneously webcast on our website: www.medical-action.com. The dial-in number for the conference call is (877) 637-9564 ( domestic) or (973) 935-8511 ( international); conference ID #99489992. The complete call and discussion will be available for replay on our website beginning at 1:00 p.m. (ET) on August 1, 2012. Medical Action is a diversified manufacturer and distributor of disposable medical devices and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The Company has expanded its target market to include physician, dental and veterinary office, out-patient surgery centers, long-term care facilities and laboratories. Medical Action’s products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. The Company has preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. Medical Action’s common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell Microcap ® Index. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.All statements other than statements of historical fact are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives for management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing.All forward-looking statements included in this news release are made as of the date hereof and are based on information available to us as of such date.The Company assumes no obligation to update any forward-looking statement.In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology.Although the Company believes that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, including manufacturing inefficiencies, termination or interruption of relationships with our suppliers, potential delays in obtaining regulatory approvals, product recalls, product liability claims, our inability to successfully manage growth through acquisitions, our failure to comply with governing regulations, risks of international procurement of raw materials and finished goods, market acceptance of our products, market price of our Common Stock, foreign currency fluctuations, resin volatility and other factors referred to in our press releases and reports filed with the Securities and Exchange Commission (the “SEC”).Please see the Company’s filings with the SEC, including, without limitation, the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Qs, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.